3 October 2026 12:00 AM

A practical framework for managing biological research, synthesis, data, and oversight while preserving beneficial scientific progress and public trust.

3 September 2026 12:00 AM

Bayesian designs can improve trial decisions through adaptation, prediction, and evidence borrowing while preserving rigorous standards for reliability.

3 August 2026 12:00 AM

Personalized genetic medicines may address unique disease variants, but scientific, regulatory, ethical, and economic barriers remain substantial.

26 July 2026 12:00 AM

Individualized genetic medicines may address exceptionally rare disorders, but evidence, manufacturing, safety, access, and regulation remain difficult.

25 July 2026 12:00 AM

Bayesian trial methods can integrate prior evidence, support adaptive decisions, and sharpen uncertainty estimates during therapeutic development.

24 July 2026 12:00 AM

An examination of how artificial intelligence can support health policy analysis while introducing new requirements for transparency, oversight, and equity.